loader
Please Wait
Applying Filters...

Fermion Oy Fermion Oy

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    List of Certificates of Suitability (CEPs) for r1_cep_2017_145___rev_00 Active Pharmaceutical Ingredient (API) issued by the EDQM. Original Data: EDQM Database

    Client Virtual Booth
    Menu

    Artivion

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    PharmaCompass

    Boai NKY Pharmaceuticals Ltd. is one of the largest global PVP suppliers.

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 ARTIVION, INC. Kennesaw US (1)

    filter

    01 Bovine pericardium (1)

    filter

    01 U.S.A (1)

    filter

    01 Valid (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us

    ARTIVION, INC. Kennesaw US

    Contact Supplier
      Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
      Post an Enquiry Post an Enquiry
      Flag U.S.A
      Virtual Booth Virtual Booth
      Digital Content Digital Content

      Bovine pericardium

      PDF Supplier PDF
      URL Supplier Web Content
      R1-CEP 2017-145 - Rev 00
      Valid
      TSE
      2022-09-29
      ASK
      US
      PHARMACOMPASS
      Upload
      your Marketing & Sales content

      Looking for Certificates of Suitability (CEPs) for R1-CEP 2017-145 - Rev 00 of Artivion, Inc. Kennesaw Us

      Looking for Certificates of Suitability (CEPs) for R1-CEP 2017-145 - Rev 00 of Artivion, Inc. Kennesaw Us 1

      20

      Artivion, Inc. Kennesaw Us, based in U.S.A, is a pharmaceutical company.

      One of their significant offerings is Bovine pericardium, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2017-145 - Rev 00

      This TSE Type CEP, issued on September 29, 2022, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.

      Post Enquiry
      POST ENQUIRY